Estrogen and Tamoxifen Modulate Cerebrovascular Tone in Ovariectomized Female Rats
- 1 July 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 44 (1) , 78-82
- https://doi.org/10.1161/01.hyp.0000131659.27081.19
Abstract
Postmenopausal estrogen deficiency increases the incidence of cerebrovascular disease. However, hormone replacement therapy is associated with an increased cardiovascular risk. Tamoxifen is a selective estrogen receptor modulator with estrogenic effects on cardiovascular risk factors, but its long-term impacts on cerebral vasculature are unknown. We hypothesized that chronic 17β-estradiol or tamoxifen treatment exerted similar effects in reducing cerebrovascular tension in ovariectomized rats. We therefore determine whether (1) chronic 17β-estradiol treatment could influence vasomotor activities, (2) chronic tamoxifen therapy could exert an estrogen-like or estrogen-antagonistic effect, and (3) acute exposure to estrogen could mimic the effect of 17β-estradiol. Isometric tension was measured in cerebral arteries from female rat groups: control, ovariectomy, ovariectomy plus 17β-estradiol treatment, ovariectomy plus tamoxifen treatment, and ovariectomized rats treated with tamoxifen and 17β-estradiol. Ovariectomy enhanced cerebrovascular contractions to endothelin-1 or CaCl 2 , but not to U46619 or phenylephrine. 17β-Estradiol therapy reversed these effects. Chronic tamoxifen treatment exerted estrogen-like actions by reversing ovariectomy-induced enhancement of vessel tone without antagonizing the effect of chronic 17β-estradiol treatment. Ovariectomy enhanced the relaxing potency of nicardipine, and 17β-estradiol treatment prevented this effect. Acute exposure to 10 −9 mol/L 17β-estradiol or 10 −8 mol/L tamoxifen did not modulate contractions in rings from nonoperated female rats. In conclusion, ovariectomy differentially enhances agonist-induced cerebrovascular tone, an effect that was reversed by estrogen therapy. Tamoxifen does not act as an estrogen antagonist; instead, it functions as an estrogen agonist during estrogen deficiency. Thus, tamoxifen may confer beneficial effects similar to estrogen in cerebrovascular vessels.Keywords
This publication has 26 references indexed in Scilit:
- Differential regulation of K+ and Ca2+ channel gene expression by chronic treatment with estrogen and tamoxifen in rat aortaEuropean Journal of Pharmacology, 2004
- Contribution of K+ Channels to Relaxation Induced by 17β-Estradiol but Not by Progesterone in Isolated Rat Mesenteric Artery RingsJournal of Cardiovascular Pharmacology, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Selective estrogen receptor modulators (SERMS) and their roles in breast cancer preventionTrends in Molecular Medicine, 2002
- 17-β-Estradiol Induces Heat Shock Proteins in Brain Arteries and Potentiates Ischemic Heat Shock Protein Induction in Glia and NeuronsJournal of Cerebral Blood Flow & Metabolism, 2002
- Estradiol Protects against Ischemic InjuryJournal of Cerebral Blood Flow & Metabolism, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- The effect of oophorectomy on mechanical properties of rabbit cerebral and coronary isolated small arteriesAmerican Journal of Obstetrics and Gynecology, 1996
- Postmenopausal oestrogen treatment and stroke: a prospective study.BMJ, 1988
- An evaluation of tamoxifen as a partial agonist by classical receptor theory — An explanation of the dual action of tamoxifenEuropean Journal of Pharmacology, 1984